Post My Press Release

Free Press Release Distribution

Category: healthcare (Page 1 of 779)

Contraceptives Drugs And Devices Market Projected to Grow Steadily During 2018-2026

Contraceptive drugs and devices that aid to control birth rate and unintended pregnancies are subject to unique regulatory challenges across different countries. For instance, contraceptive drugs and devices face reimbursement challenges in the U.S., while contraceptive pills face advertising restrictions in India. Owing to this, contraceptives preference greatly various across countries. Statistics revealed by the United Nations in 2015, highlight this trends, with a particular contraceptive accounting for over 50% share across 45 countries considered in the study. Sterilization is a dominant contraceptive method in regions such as Asia, North America, and Latin America as per the study. Intra-uterine devices (IUDs), vaginal rings, injectables, implants, combined oral contraceptives, and patches are some of the more advanced contraceptive methods available in the market. Introduction of new male contraceptive products with high success rate are projected to shape the course of growth of the market in the near future.

Get HOLISTIC Request Sample Copy Of This Business Report:

https://www.coherentmarketinsights.com/insight/request-sample/365

Favorable reimbursement scenario in the U.S. to propel uptake of contraceptives

The affordability and accessibility of products to the U.S. citizens will be affected due to the new policies of President Trump on the Affordable Care Act. However, insurance coverage of health and reproductive products were allowed to be continued without any co-pays, co-insurance or deductibles by the State. Furthermore, this new policy would also cover all medically essential abortion services for the U.S. population. This is a much anticipated relief for the general population in the U.S., as around 45% of all pregnancies reported are unintended (CDC, 2009-2013 study data).

High preference for modern contraceptive methods in developed regions

As per results of a detailed study by the United Nation in 2015, 9 out of 10 married or in-union women opt for modern contraceptive methods. Use of IUD in the U.S. women population has resulted in decrease in the rate of unintended pregnancies from 51% (2006–2010) to 45% (2009–2013) as per the CDC’s National Survey of Family Growth. Furthermore, higher success rate and availability of reimbursement is encouraging women to opt for these methods over contraceptive pills. With increasing consumer awareness and rising accessibility to modern contraceptives methods, demand for these products is expected to increase in emerging economies such as India, China, and Brazil during the forecast period. Gynecologists and sexologists are recommending use of long-acting reversible contraceptives for couples who do not intend to have a child in near future, owing to their low side-effects and high effectiveness as compared to conventional contraceptives such as oral hormonal pills.

Factors impacting the contraceptive drugs and devices market in different regions:

  • Implementation of the stringent two-child policy in China since 2016, is a major factor driving demand for contraceptives in the country
  • Societal stigma impacting the demand for contraceptives negatively in Asia and Africa
  • Government programs encouraging the use of selected contraceptives affecting the market for other products (Indian government provides incentives for sterilization and distributes free condoms, while the U.S. Affordable Care Act emphasizes on complete insurance coverage for long-acting reversible contraceptives (LARC)

The global contraceptive drugs and devices market was valued at US$ 18,273.2 million in 2015 and is expected to expand at a CAGR of 7.8% during the forecast period (2016 – 2024).

Click To Reading More On Contraceptives Drugs And Devices Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

Emergency Medical Equipment Market Revenue Growth 2026

Emergency Medical Services (EMS) require specialized equipment to aid in the provision of emergency care. The rapid development of medical technology has transformed the international EMS systems with introduction of multifunctional compact monitoring systems. These equipment are making the task of monitoring patients manageable in an uncontrolled environment of pre-hospital settings.

Request for Sample Copy of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/2161

Market Dynamics

Increasing geriatric population prone to various medical emergencies such as cardiac arrest, respiratory disorders, and other medical urgency and rising incidences of natural calamities require advanced emergency medical care. According to American Heart Association 2016 report, cardiovascular disease is the leading cause of death worldwide, accounting for around 17.3 million deaths annually and is expected to reach over 23.6 million by 2030.

According to GRID-Arendal, an official United Nations Environment Programme (UNEP) 2018, with the growing population and infrastructures, the world’s exposure to natural hazards is increasing inevitably. Therefore, all these factors are collectively rising the demand for emergency medical services eventually driving the emergency medical equipment market revenue.

Despite the increasing demand, the emergency medical services varies drastically from developed to developing countries.

For instance, according to the Journal of Emergency Medical Services, in 2019, India will host the Asian Conference on Emergency Medicine, which is expected to be attended by major industry players, and India is a good entry point for the entire subcontinent.

Emergency Medical Equipment Market – Competitive Landscape

Key players operating in the global emergency medical equipment market include 3M, Abbott, Asahi Kasei Corporation, B. Braun Medical, BD, Cardinal Health, GE Healthcare, Henry Schein, Johnson & Johnson, Philips Healthcare, Smith & Nephew, and Stryker Corporation.

Request for Customized Report :https://www.coherentmarketinsights.com/insight/request-customization/2161

Detailed Segmentation:

  • Global Emergency Medical Equipment Market, By Product Type:
    • Diagnostic Medical Equipment
    • Emergency Resuscitation Equipment
    • Personal Protective Equipment
    • Patient Handling Equipment
    • Other Equipment
  • Global Emergency Medical Equipment Market, By Application:
    • Cardiac Care
    • Cancer Care
    • Respiratory Care
    • Trauma
    • Other Applications

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa

Pregnancy Test Kits Market in depth study and analysis published, 2018

Market Scenario:

Pregnancy test kits are medical devices which are used to identify the possibility of pregnancy in females. The device senses tiny amount of HCG (Human Chorionic Gonadotrophin; female pregnancy hormone), the amount of which increases during early stages of pregnancy in the female body. Continuous technological advancements in pregnancy test kits, rising demand of self-contained and quick test results and growing age of first pregnancy are some of the major issues, which are likely to bolster the growth of global pregnancy test kits market over the forecast period.

However, rising new small players with a very little or no medical equipment business history, and a huge price gap between the top players and small un-organized players’ are some of the factors which are hindering the growth of global pregnancy test kits market in the future.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/2982

Segments:

The Global Pregnancy Test Kits Market is segmented on the basis of type of test, product and end users. Based on the type of test, the market has been segmented as blood test for HCG, Urine test for HCG and others. Based on products, the market has been segmented into digital devices, line indicators which are further segmented into strips, cassettes and mid-stream devices and others. Further on the basis of end users, the market has been segmented into hospitals, clinics, households and others.

Key players of Global Pregnancy Kits Market:

Key players profiled in the report are

  • Alere Inc.
  • Prestige Brands Holdings, Inc,
  • Quidel Corporation
  • Procter & Gamble Co.
  • Piramal Enterprises
  • Cardinal Health
  • Confirm Biosciences

Regional analysis

North America accounts for the maximum market share of the pregnancy test kits market and the market is expected to increase continuously in coming years. This can be attributed to increasing pool of aware females along with need for household determination of pregnancy. Advancing technologies within the pregnancy test kits or instant pregnancy tests is also driving the market and will see strategic growth over the next five years. Asia pacific with the upcoming developments in healthcare and increasing awareness and per capita income is expected to command the maximum market share of the market.


Browse Complete 85 Pages Premium Research Report Enabled With Respective Tables And Figures @ https://www.marketresearchfuture.com/reports/pregnancy-test-kits-market-2982

Detailed Table of Contents:

1 Introduction

1.1 Definition

1.2 Scope Of Study

1.2.1 Research Objective

1.2.2 Assumptions & Limitations

1.2.2.1 Assumptions

1.2.2.2 Limitations

1.3 Market Structure:

2 Research Methodology

2.1 Research Process:

2.2 Primary Research

2.3 Secondary Research:

3 Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Macroeconomic Indicators

4 Market Factor Analysis

4.1 Porters Five Forces Model

4.2 Bargaining Power Of Suppliers

4.3 Bargaining Power Of Buyers

4.4 Threat Of New Entrants

4.5 Threat Of Substitutes

4.6 Intensity Of Rivalry

5 Global Pregnancy Test Kits Market, By Type Of Test

5.1 Blood Test For Hcg

5.2 Urine Test For Hcg

5.3 Others

…Continued

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Diabetes Market Value Share, Supply Demand, share and Value Chain 2018

Market Scenario:

The report for Middle East and Africa Diabetes Market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

Middle East and Africa Diabetes Market is growing rapidly. Middle East and Africa Diabetes Market is expected to grow at a CAGR of 5.1% and expected to reach US$ 16.4 billion by 2023 from US$ 11.6 billion in 2016.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/2971

On an average one in ten adult is suffering from diabetes in Middle East and Africa region. Most of the case are of Type 2 diabetes and it is growing rapidly. According to International Diabetes Federation Atlas, about 19.3% of population between 20-79 age group is diabetic in UAE and the number is almost same in Saudi Arabia, Qatar, Kuwait and Bahrain. These five nations has the highest rate of diabetes per capita which is among the top 15 countries in the world. Increasing urbanization, changing lifestyle and unhealthy eating habits are driving the growth for the market. Rising middle class group, increasing per capita income, spending on healthcare and advanced healthcare infrastructure facilities are driving the growth for the market in this region.

Segments:                                                                                                                                        

Middle East and Africa Diabetes Market has been segmented on the basis of type which comprises Type 1, Type 2, and Gestational diabetes. On the basis of test, market is segmented into Random blood sugar test, Fasting blood sugar test, Oral glucose tolerance test, Initial glucose challenge test and others. On the basis of devices, it is segmented into Blood glucose monitoring devices, Diabetes management devices, and others. On the basis of treatment market is segmented into Medications, Insulin therapy, Transplantation, Bariatric surgery and others.

Regional Analysis

Considering the scenario of the Middle East and African diabetes market, Saudi Arabia is believed to be the largest market for diabetes. Moreover the UAE also growing and second largest market for Middle East and Africa Diabetes. On the other hand, Egypt market is expected to grow at significant rate in the Middle East and Africa diabetes during the forecasted period. Rest of Middle East and Africa is likely to have a limited but moderate growth in the market.

Key Players

Some of the key players in this market are: Abbott (US), Bayer AG (Germany), Becton Dickinson and Company (US), Johnson & Johnson Services, Inc. (US), Merck & Co., Inc. (US), Novartis AG (Switzerland), Novo Nordisk A/S (Denmark), Roche Diabetes Care, Inc. (US), sanofi-aventis U.S. LLC (US), Ypsomed (Switzerland)

Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/2971

List of Tables and Figures:

List Of Tables

Table 1 Middle East and Africa Diabetes Market By Type

Table 2 Middle East and Africa Diabetes Market By Test

Table 3 Middle East and Africa Diabetes Market By Devices

Table 4 Middle East and Africa Diabetes Market By Treatment

Table 5 Middle East and Africa Diabetes Market By Region

List Of Figures

Figure 1 Research Process

Figure 2 Porters Five Forces Model

Figure 3 Middle East and Africa Diabetes Market By Type

Figure 4 Middle East and Africa Diabetes Market By Test

Figure 5 Middle East and Africa Diabetes Market By Devices

Figure 5 Middle East and Africa Diabetes Market By Treatment

Figure 7 Middle East and Africa Diabetes Market By Region

Figure 8 Middle East and Africa Diabetes Market By Region: Company Share Analysis, 2015 (%)

…Continued

Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/2971  

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Encephalomyelitis Market – Market Demand, Growth, Opportunities and Analysis of Top Key Player Forecast To 2023

Market Scenario

Encephalomyelitis is brain or spinal cord inflammation caused due to virus, infections, and other foreign particles. The patient suffering from autoimmune diseases and AIDS are more prone to the diseases. A wide range of drugs are available for the treatment of this disease, however no precise treatment is available to cure the disease. Increasing prevalence of encephalomyelitis and autoimmune diseases has boosted the growth of the market. According to the WHO, 4.3 million people across the globe are affected by this disease. Additionally, changing lifestyle, increasing geriatric population, increasing need for better treatment has driven the global market. Moreover, increasing government support along with the per capita income have fuelled the market growth. However, limited and high cost of treatment options may retard the growth of the market over the assessment period.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/4874

The global encephalomyelitis market is expected to grow at a CAGR of ~8.1 % during the forecast period 2017-2023. 

Segmentations

The global encephalomyelitis market is segmented on the basis of types, treatment and end users.

On the basis of types, the market is segmented into acute disseminated encephalomyelitis, encephalomyelitis disseminata, antiMOG associated encephalomyelitis, equine encephalomyelitis, AIDS related encephalomyelitis and others.

On the basis of treatment, the market is segmented into drug treatment, plasmapheresis, surgery, and others. Drug therapy is further segmented into antiviral medications, antibiotics, steroids, sedatives, NSAIDs, mood stabilizers, and others.

On the basis of end users, the market is segmented into hospital, clinics and others.

Regional Analysis

The Americas command a major share of the market owing to the large patient population, growing prevalence of encephalomyelitis & autoimmune diseases, and strong government support for research & development. According to the American Autoimmune Related Diseases Association, approximately 50 million people in the U.S. were reported to be suffering from autoimmune diseases in 2014.

Europe accounts for the second largest market across the globe, which is followed by Asia Pacific. Strong government support, availability of funds for research and high healthcare expenditure drives the growth of the market. Asia Pacific is the fastest growing market. China, and India are the key contributors to the market growth due to presence of huge population base, increasing prevalence of AIDS and autoimmune diseases, rapidly growing economy, and increasing healthcare expenditure. Additionally, increasing government support, and presence of huge opportunity have fuelled the growth of the market in Asia Pacific.

The Middle East & Africa holds the least share of the global market due to limited availability of medical facilities and poor economic condition in African region. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market owing to the well-developed economy and high healthcare spending.

Key Players

Some of key the players in the market are Bristol-Myers Squibb Company (U.S.), Sanofi (France), GlaxoSmithKline Plc. (U.K), Spectrum Pharmaceuticals Inc. (U.S.), Amgen, Inc. (U.S.), Merck & Co., Inc. (U.S.), Bayer AG (Germany), Novartis AG (Switzerland), F. Hoffmann-La Roche Ltd. (Switzerland), Eli Lilly and Company (U.S.), AstraZeneca Plc. (U.K), Janssen Biotech, Inc. (U.S.), AbbVie Inc. (U.S.), Takeda Pharmaceuticals (Japan), Immunomedics (U.S.), Pfizer, Inc. (U.S.), and Oncomed Pharmaceuticals (U.S.).

Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/4874

Detailed Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

…Continued

Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/4874

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Retropharyngeal Abscess Market Value Share, Supply Demand, share and Value Chain 2018

Market Synopsis of Global Retropharyngeal Abscess Market:

Market scenario:

A retropharyngeal abscess is a serious infection, usually starts in the lymph nodes, characterised by collection of pus at the back of the throat. Retropharyngeal abscess typically occurs in children under the age of eight, sometimes it can also affect adults. The symptoms of retropharyngeal abscess include difficulty or noisy breathing, difficulty and pain while swallowing, drooling, severe cough, severe throat pain, neck stiffness or swelling, muscle spasms in the neck among others. Retropharyngeal abscess is generally preceded by upper respiratory infections mostly a middle ear or sinus infection.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/4922

The causes of retropharyngeal abscess are trauma or injury, medical procedure, dental procedures, alcohol intake, diabetes, cancer, AIDS, weakened immune system or a chronic diseases such as tuberculosis and others. Other complications indicated are pneumonia, blood clots in the jugular vein, mediastinitis, osteomyelitis and others. If left untreated, retropharyngeal abscess infection can spread to other parts of the body resulting in septic shock and organ failure. In severe instances, a retropharyngeal abscess can lead to death. The most common bacteria involved are Streptococcus, Staphylococcus, and others. Other infections, such as HIV and tuberculosis can also cause the retropharyngeal abscess. Retropharyngeal abscess recurs in an estimated 1 to 5% of patients and such patients are 40 to 50% more likely to die due to abscess-related complications. Retropharyngeal abscess also slightly more common in males than females.

The market drivers for global retropharyngeal abscess market, are rise in demand due to the growing younger and susceptible population, increasing screening, urgency of the retropharyngeal abscess treatment, and rise in risk factors. The rise in cases of retropharyngeal abscess due to increase in Methicillin-resistant Staphylococcus aureus (MRSA) infections also stimulates the market. The market restraints are complications such as risk of bleeding, infections, pain, especially during surgery, high cost of retropharyngeal abscess treatment, lack of cardiac care infrastructure, and lack of focus on other diseases by the developing regions and others.

The global retropharyngeal abscess market is expected to reach USD 5.9 billion by 2023, and the market is projected to grow at a CAGR of ~ 4.5 % during the forecast period 2017-2023.

Segments
The global retropharyngeal abscess market has been segmented on the basis of diagnosis, treatment, and end user.

Based on the diagnosis, the market has been segmented as X-rays and computed tomography, blood tests, physical exam and others.

Based on the treatment, the market has been segmented as calcium antibiotics, pain killers, surgical drainage and others.

Based on the end user, the market has been segmented as hospitals and clinics, research and academics and others.

Regional Analysis
A significant market share of the global retropharyngeal abscess market is held by the Americas, owing to high expenditure on the health care especially in major countries of the region like the U.S. and Canada. Additionally, the number of cardiac procedures in the U.S and Canada is increasing due to greater healthcare penetration, which drives the retropharyngeal abscess market. The high concentration of the major hospitals in the developed countries of this region coupled with good reimbursement rates is adding fuel to the market growth. Moreover, the large share of infective procedures treatment in the returns of hospitals favors the market. The large number of pharmaceutical companies in the U.S. is also a cause for the faster development of retropharyngeal abscess market in the US. The development of broad spectrum antibiotics in developed regions such as the U.S. and Europe is a strong driver of the market.

Europe is the second largest market in the world due to growing pharmaceutical industry and healthcare penetration. The European market growth is led by countries such as Germany and France. Germany is expected to be the fastest growing market over the assessment period due to its large pharmaceutical and microsurgery devices industry. The development of Methicillin-resistant Staphylococcus aureus (MRSA) especially in the southern regions of Europe such as Spain, Italy etc. stimulates the market.

Asia Pacific region is expected to grow rapidly; China and India are likely to lead this market due to fast growing healthcare sector and large unmet needs over the forecast period. South East Asian countries such as China, India, and Malaysia are projected to contribute highly to the market growth. The growing penetration of healthcare industry in the Asia Pacific region is expected to drive the future retropharyngeal abscess market in the region. However the low expenditure on healthcare coupled with the poor incomes in the developing regions is a dent on the market.

Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. Other Middle East nations to watch out for are Kuwait, Jordan, Egypt and Iran. The African region is expected to witness a poor growth owing to poor economic and political conditions, and poor healthcare development. Other regions are expected to be laggards due to poor social development and tribal identities such as sub Saharan Africa.

Key Players in the Global Retropharyngeal abscess Market
Some of the key players profiled in the report are Merck KGaA, Johnson & Johnson, AstraZeneca plc, Sanofi S.A., Pfizer, Mylan N.V, Novartis AG, Teva pharmaceutical company, GlaxoSmithKline plc., and others.

Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/4922

Detailed Table of Contents:

Table Of Contents

1. Introduction

1.1 Definition

1.2 Scope Of Study

1.2.1 Research Objective

1.2.2 Assumptions & Limitations

1.2.2.1 Assumptions

1.2.2.2 Limitations

1.3 Market Structure:

2. Research Methodology

2.1 Research Process:

2.2 Primary Research

2.3 Secondary Research:

3. Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Macroeconomic Indicators

4. Market Factor Analysis

4.1 Porters Five Forces Model

4.2 Bargaining Power Of Suppliers

4.3 Bargaining Power Of Buyers

4.4 Threat Of New Entrants

4.5 Threat Of Substitutes

4.6 Intensity Of Rivalry

…Continued

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312 Email: sales@marketresearchfuture.com

Current and forthcoming Microsurgery Market size in terms of volume and value 2018

Market Scenario
Development of microsurgical techniques has enable surgeons to carry out surgical procedures on human body at micro level. Microsurgery typically combines specialized precision instruments and magnification techniques during surgery. Today, microsurgical techniques are utilized by several specialties including ophthalmology, gynecological surgery, neurosurgery, plastic surgery, pediatric surgery, general surgery, orthopedic surgery, otolaryngology, podiatric surgery and oral and maxillofacial surgery among others. Microsurgery procedure are also effective in congenital deficiencies and cancer treatment, as they aid in healing wounds faster and restoring function after trauma. Over the past couple of decades, popularity of microsurgery has increased to a significant extent. In addition, increased prevalence of ophthalmic disorders and other chronic ailments is necessitating such advanced surgical procedures. Market Research Future (MRFR)’s the global market for microsurgery will witness an impressive CAGR of 10.2% during the assessment period (2017-2023).

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/4214

Segments    
The global microsurgery market is segmented on the basis of application, procedures, and end users. On the basis of applications the market is categorized into: general surgery, ophthalmology, plastic surgery, gynecological surgery, orthopedic surgery, oncology, neurosurgery, oral & maxillofacial surgery, podiatric surgery, and pediatric surgery.

On the basis of procedures the market is segmented into free tissue transfer, replantation, transplantation, and treatment of infertility. Replantation is further segmented into fingers & thumbs, ear, scalp, nose, and others. Treatment of infertility is further segmented into tubal obstructions, vas deferens obstructions and varicocele.

On the basis of end users the market is segmented into hospitals & clinics, research organizations and others.

Key Players         
Some of the key players in microsurgery market are AROSurgical Instruments (US), tisurg medical instruments Co., Ltd (China), Carl Zeiss Meditec AG (Germany), MicroSurgical Technology (US), SYNOVIS MICRO COMPANIES ALLIANCE, INC. (US), Peter LAZIC GmbH (Germany), BIONIKO (US), MICROSURGERY INSTRUMENTS, INC. (US).

Regional Analysis                
The Americas account for the largest share of the global market owing to increasing cancer population, increasing prevalence of neurological diseases and deficiency diseases, and high healthcare spending. According to Centers for Disease Control and Prevention (2014), over 1.5 million cases of invasive cancer, including about 15,000 cases among children younger than 20 years are registered every year. Beside this increasing government support for research & development has supported the growth of the market.
Europe accounts for the second largest market which is followed by Asia Pacific. Availability of funds for research & development, increasing awareness about availability of treatments and well developed healthcare sector drives the market of microsurgery. On the other hand, Asia Pacific holds the fastest growth for microsurgery market owing to increasing number of people suffering from chronic diseases, elevating geriatric population, and demand for better treatments are the key factors for the market growth. China and India holds the major share for the market due to large patient pool.
The Middle East & Africa is expected to show steady growth in this market due to low technology penetration and limited availability of innovative healthcare technologies.

Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/4214

Detailed Table of Contents:

1 Report Prologue

2 Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3 Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs Of The Market

12.2 Key Companies To Watch

12.3 Prediction Of Medical Devices Industry

13 Appendix

…Continued

Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/4214

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Cardiopulmonary Disease Diagnostics and Treatment Market Expected to Grow at High Cagr during Forecast Period 2018 – 2023

Market Synopsis of Global Cardiopulmonary Disease Diagnostics and Treatment Market:

Market Scenario:

The cardiopulmonary disease is used to describe a wide range of series of disorders which affect the heart and the lungs. Cardiovascular disease is a universal term for conditions affecting the heart or blood vessels. It’s usually related with a build-up of fatty deposits inside the arteries known as atherosclerosis. It can also be related with an injury to arteries in organs such as the brain, kidney, and heart. Respiratory disease is a medical term that includes extreme conditions affecting the organs and tissues which make gas exchange possible in higher organisms. Respiratory diseases range from mild to self-limiting, such as the common cold, to life-threatening entities like bacterial pneumonia, pulmonary embolism, and lung cancer.

Treatment options vary depending on the type of cardiopulmonary disease present and may include changes in diet or lifestyle, use of medications issued on prescription or surgery. The most common cardiopulmonary diseases are hypertension, stroke, and coronary heart disease. Untreated, cardiopulmonary diseases can be deadly. Cardiopulmonary diseases are the major cause of death globally.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/6390

The substantial growth in the frequency of health conditions related to the lungs and heart is the key factor to boosts the growth of this market. Also, the increase in aged population and the rising frequency in cardiovascular and respiratory diseases is also anticipated to drive the global market over the forecast period. Exposure to nicotine, tobacco products, and others increases the risk of obtaining cardiopulmonary diseases.

Increase in the rise of advanced technological equipment’s for diagnosing the disease will drive market rate exponentially. However, the huge cost of treatment and the regulatory nature of government on pharmaceutical companies will hamper the growth of the market.

Segmentation

The global cardiopulmonary disease diagnostics and treatment market has been segmented on the basis of disease type, type, and end-user.

On the basis of disease type, the market has been classified as cardiovascular and respiratory diseases. The cardiovascular diseases are segmented into coronary artery disease, angina pectoris, myocardial infarction, dysrhythmia, hypertension, and others. The respiratory diseases are segmented into influenza, asthma, bronchitis, emphysema, cystic fibrosis, and others.

On the basis of type, the market has been classified as diagnosis and treatment. The diagnosis market is segmented into an electrocardiogram (ECG), Holter monitoring, echocardiogram, stress test, cardiac catheterization, cardiac computerized tomography (CT) scan, cardiac magnetic resonance imaging (MRI), single-photon emission computed tomography (SPECT), stress blood pressure monitors, pulse oximeters and spirometry. The treatment market is segmented into medications. The medications segment is further sub-segmented into angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBS), anticoagulants, antiplatelet agents and others.

On the basis of end users, the market has been classified as hospitals, clinics, diagnostic centers, specialty clinics and rehab centers, research institutes and others.

On the basis of region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas has been further segmented into North America and South America, with the North American market divided into the US and Canada.

The European cardiopulmonary disease diagnostics and treatment market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 

The cardiopulmonary disease diagnostics and treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The cardiopulmonary disease diagnostics and treatment market in the Middle East and Africa has been segmented into the Middle East and Africa.

Regional Market Summary

In the cardiopulmonary disease diagnostics and treatment market, North America is anticipated to account for the largest market share due to the early adoption of advanced medical technologies, the rise in awareness, the rise in growth of the healthcare sector, and due to favorable compensation setting for many surgical procedures.

 The European market is expected to hold the second largest market share. The market growth in this region can be attributed to rising frequency of cardiovascular disorders, increasing number of surgeries and increasing demand for advanced treatment procedures are boosting the European market.

The market share in Asia-Pacific is also projected to experience growth in the near future due to access to optimal treatment facilities and growing demand for advanced technology, better adoption rate, increase in disposable income, and rising medical tourism.

The market in the Middle East and Africa is expected to account for the smallest share of the global cardiopulmonary disease diagnostics and treatment market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.

Key Players

Some of the key players in the global cardiopulmonary disease diagnostics and treatment market are Cardinal Health, Cosmed Medical, GE Healthcare, Halma plc, Hill-Rom Holdings, Inc., Koninklijke Philips N.V., MGC Diagnostics Corporation, NIHON KOHDEN CORPORATION, Schiller AG, Masimo Corporation, and Vyaire Medical Inc.

Browse Complete 85  Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/cardiopulmonary-disease-diagnostics-treatment-market-6390

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312 Email: sales@marketresearchfuture.com

Page 1 of 779

Powered by WordPress & Theme by Anders Norén